From: Pathways to ischemic neuronal cell death: are sex differences relevant?
Author | Age* | Insult | Treatment/drug/mutation | Sex difference | Key molecules |
---|---|---|---|---|---|
Du, L [21] | Neurons | Cytotoxic agents | estradiol, NMDA antagonist, z-VAD, PARP inhibitor, antioxidants | Yes | AIF, cytochrome C, glutathione |
Hagberg, H [53] | Neonatal | 50 minutes unilateral hypoxia-ischemia | PARP-1 -/- | Yes | NAD+, PAR |
Heyer, A [37] | Neurons | 15 hr. Hypoxia | testosterone | Yes | sex hormones, estrogen receptors |
Kitano, H [60] | Neonatal and adult | 2 hr. MCAO | isoflurane PC, Akt KO | Yes | Akt, NIPK |
Li, H [48] | Neurons | Oxygen-glucose deprivation & NMDA | 7-nitroindazole, estradiol | Yes | SOD, NO(x) |
Li, K [57] | Juvenile | Embolic infarct | None | Yes | various cytokines |
Liu, M [38] | Astrocytes | Oxygen-glucose deprivation & cytotoxic agents | Arimidex, estradiol | Yes | cyp19 mRNA, aromatase activity |
Mabley, J. G. [12] | Adult | LPS injections | OVX, PARP-1 -/- | Yes | TNF, PAR, Erα |
Mcullough, L. D. [4] | Adult | 90 min. MCAO | nNOS -/-, PARP- 1-/-, OVX, PJ-34, 7-nitroindozole | Yes | eNOS, iNOS, nNOS |
Nijboer, CH [11] | Neonatal (P7) | 2 hr. Hypoxia-ischemia | 2-iminobiotin | Yes | AIF, cytochrome C, caspase-3 |
Nijboer, CH [51] | Neonatal (P3) | 2 hr. Hypoxia-ischemia | 2-iminobiotin | Yes | AIF, cytochrome C, caspase-3, HSP70 |
Park, EM [59] | Adult | 20 min. MCAO | OVX, PARP-1 -/-, aminoguanidine, iNOS-/- | Mixed | iNOS |
Renolleau, S [22] | Neonatal | 50 min. MCAO | Q-VD-Oph | Yes | cytochrome C, caspase-3, caspase-1 |
Wen, TC [23] | Neonatal | permanent MCAO | Erythropoietin | Yes | None |
Zhang, L [42] | Neurons | None | None | Yes | Phospho-ERK1, Akt, Bcl-2 |
Zhu, C [54] | Neonatal | 45 min. Unilateral hypoxia-ischemia | Q-VD-OPh, Edaravone, Harlequin mutation | No | AIF, cytochrome C, caspase-3, PAR |
Zhu, C [56] | Neonatal and Adult | 45–65 min. Unilateral hypoxia-ischemia | None | Mixed | AIF, cytochrome C, caspase-3, PAR, nitrotyrosine |